What are the domestic companies that do antibody customization?

Domestic antibody customization companies include Jin Kairui Bioengineering. After all, for researchers, the development of domestic antibody customization companies is directly related to their experiments, but there are indeed many domestic antibody customization companies.

The polyclonal antibody production platform of Kim Kairui has established a series of technology platforms and animal breeding bases with the antibody platform as the core. Polyclonal antibodies are present in the serum of immunized animals and can be obtained by direct isolation of serum.

With the antibody platform as the core, the Kingcash Bioengineering Antibody Center has established a series of technology platforms and animal breeding bases, specializing in antibody production and antibody customization, for you to freely choose your special needs! Hope it helps.

Shanghai Xinhao Biotechnology, Wuhan Jinkairui Bioengineering.

Name: Shanghai Xinhao Biotechnology****.

Company type: limited liability company (domestic joint venture).

Date of Establishment: 2015-06-15.

Operating period: 2015-06-15 to 2025-06-14.

Business scope: engaged in technology development, technical consultation, technology transfer, technical services, instrumentation, machinery and equipment, sales of chemical raw materials and products (except hazardous chemicals, monitoring chemicals, fireworks, civil ** items, precursor chemicals) in the field of biotechnology and chemical science and technology, and engaged in the import and export of goods and technologies.

Wuhan Jinkairui Bioengineering Co., Ltd. is a professional provider of biotechnology and medical health-related technical services for major pharmaceutical companies, diagnostic reagent companies, scientific research reagent research and development companies, major university research institutes and clinical departments of large hospitals, and provides comprehensive and in-depth biotechnology services in molecular biology, biochemistry, cell biology, immunology and various interdisciplinary fields. Advantageous services include gene synthesis, vector construction, proteomics services, virus packaging, antibody production, etc.

The list of innovation power of China's antibody drug companies is released:

BeiGene, Cinda, Junshi Rongchang, Akeso, Alphamab Oncology, Henlius, Bio-Thera, I-Mab, Sunshine Guojian, Shenzhou Cell, Biocytogen, Tianguangshi, Kangnuoya, Genho, etc.

The role of antibodies:

1. Antibodies play a great role in biology, such as neutralizing toxins and preventing the invasion of pathogens, which can simply prevent the invasion of various viruses in the human body.

2. Antibodies can also recognize and specifically bind antigens, which is their main function. Boosts the body's immunity, and the antibodies of newborn babies can also fight infections.

3. Antibodies are equivalent to antibiotics, which are designed to destroy and destroy germs, but if it is a long-term or multiple infection, the role of antibodies will be greatly reduced.

How to Enhance Antibody Function:

1. It can be enhanced with the help of sleep, sleep is closely related to the body's immunity, and a sleep factor will be produced during sleep, which will promote the increase of white blood cells, so as to eliminate the invading bacteria and viruses.

2. There is also the need to maintain an optimistic mood and a positive attitude, which is also necessary to maintain an optimal state of the human body. Know how to relieve your own stress.

3. Participate in regular exercise and make a perfect fitness plan for your body. Don't overdo it either, as long as your heart beats faster.

The top five domestic antibody companies are Shanghai WuXi AppTec, Innovent Biologics, Nanjing GenScript Biotech, Wuxi WuXi Biologics, and Jiangsu Simcere Pharmaceutical.

1.Shanghai WuXi AppTec new drug development****.

Founded in December 2000, WuXi AppTec is an open capability and technology platform company for pharmaceutical, biotechnology and medical device R&D, with operations in both China and the United States.

2.Innovent Biologics****.

Since its establishment, the company has distinguished itself among biopharmaceutical companies with its innovative achievements and international operating model. It has established a product chain including 26 new drug varieties, covering multiple disease fields such as tumors, metabolic diseases, and autoimmunity, and 5 products have been approved for marketing, of which 1 product marketing application has been accepted by the NMPA.

The NDA for sintilimab in the U.S. has been accepted by the FDA, 5 products have entered Phase III or pivotal clinical studies, and 15 products have entered clinical studies.

3.Nanjing GenScript Biotech****.

Since its inception in 2002, GenScript has grown rapidly to become one of the largest biotechnology companies, headquartered in New Jersey, USA, with offices in Europe, Japan and China. GenScript has been committed to providing high-quality research services to scientific research institutions around the world, and has provided life science research products and services to scientists in more than 100 countries around the world.

4.Wuxi WuXi Biologics Co., Ltd. ****.

As a Hong Kong-listed company, WuXi Biologics provides a full range of end-to-end R&D services to global biologics and biotech companies, helping anyone and any company discover, develop, and manufacture biologics from concept to commercialization, accelerating the global biologics development process, reducing R&D costs, and benefiting patients.

5.Jiangsu Simcere Pharmaceutical****.

Simcere Pharmaceutical is a pharmaceutical company driven by innovative R&D and committed to collaborative innovation, with the "State Key Laboratory of Translational Medicine and Innovative Drugs", and has established four R&D innovation centers in Shanghai, Nanjing, Beijing and Boston. With the corporate mission of "enabling patients to use more effective drugs as soon as possible", the company focuses on the three major areas of oncology, nervous system and autoimmunity, and actively and prospectively lays out disease areas with significant clinical needs in the future.

Founded in 1986, it is a multinational company with subsidiaries in Germany, France, the United Kingdom, the United States, China and Australia, headquartered in Oslo, Norway. The head office has been committed to the research, production and sales of magnetic separation technology and HLA related products. After years of development, its product line has covered immunology, molecular biology, microbiology, HLA and other life science fields.

In 1996, Dynal Biotech ASA passed the ISO9001 quality system certification; In 2002, two series of products obtained CE certification; In 2003, it passed ISO9001:2000 and ISO13485 quality system certification again. In March 2004, its products passed the US FDA certification.

In February 2005, Invitrogen acquired Dynal Biotech.

Acquired by Millipore for neurobiology, extracellular matrix, signaling and infectious disease research, a world-renowned company specializing in the development and distribution of life science reagents. The company has a strong R&D background, is the owner and exclusive producer of many biochemical reagent technologies such as ESGRO and LIF patents, the company has a strict quality control system and a very perfect after-sales service system, and has established a good reputation among customers.